Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don’t we have an ownership position in alphazyme?
Who knows but one poster commented with the following; @greenJack Also, the timing is perfect since Mark said the productivity on that molecule should be finished by end of May and then suddenly June 1st the big pharma signs. It has to be DYAI. Finally!
They work with vtt and bdi and have over 20 deals with major companies/organizations who are all paying to test out their platform like serum institute, iibr, sanofi, zapi, Wuxi, utrecht, university of Oslo, 3 of the top 4 animal health companies, Mitsubishi tanabe etc plus they have almost $40 million in cash, very low burn rate with no intention to dilute
Dyai has stated they have a platform that can produce billions of vaccines within a month or so. They are currently working with zapi, iibr and utrecht on a covid vaccine and perhaps other companies using their C1 platform
NERV fails
$ADAP SPEAR T-cells Targeting MAGE-A4 Demonstrate New Responses in Esophagogastric Junction (EGJ), Lung, and Head and Neck Cancers – Late Stage Development Initiated in EGJ Cancer
$IOVA prices $525M offering. 16.93M shares at $31/share
That’s nothing compared to what ABIO did today
$500 million offering by IOVA
$3 billion should cut it
Sanofi to sell its 20% equity stake in Regeneron, taking ownership down from 23.2m shares to 400k
https://ml-eu.globenewswire.com/Resource/Download/7719046f-b73f-46d3-abbe-f32b7725f1fc
So would this mean amrn entering into the covid arena may actually be a bad thing for them? They will prove taking their drug may cause more harm than good when fighting against the virus
who knows. mark rarely ever announces anything unless it's through a slide presentation or earnings. it always irked me that he rarely announces new deals/data etc in a PR so the public can see it versus us having to find it on their website and shuffle through the slides to see what is new and what is old
Lol, well my mom makes the best matzah ball soup so we could be a supplier
Campbell's to test their beef with vegetables and barley soup on covid19!!
thanks. they have an expression platform capable of producing billions of doses within a month or two for much cheaper than most platforms. it's crazy what they can do. they are working with the top companies like wuxi, sanofi, and 3 of the top 4 animal health companies and major groups like IIBR, Serum institute and Zapi. I think they have over 20 deals all of whom are paying to test the platform. I know DYAI has been working closely with IIBR for a few years so i though you may be interested. DYAI has close to $40 million in cash and their ceo states over and over again they will not issue shares/dilute.
Thanks. I don’t think Moderna is far ahead. We don’t know the true efficacy and safety of their drug yet and I’ve heard some say the results are questionable right now. Even if they are first to market, that doesn’t mean in the end they will have the best vaccine. We are still tying to improve on the flu vaccine. If nothing else, the fact that several companies may be using C1 to develop a covid vaccine in the biggest competitive race to find a cure we have going on right now is very nice validation. I still think our success will start in animal health given our collaborations with many animal health companies. From the last call, it sounds like those relationships are expanding and strengthening. I am hopeful we are close to signing a deal where we actually get money. Mark needs to show there is such interest in c1 that he’s able to monetize it. This is a huge quarter for mark. He made a lot of statements in the last call. No way he can go another quarter and then at the next earnings call say the same thing
Which comment? For some reason my awful phone won’t let me open the link
GMDA prices offering. 13.33M shares at $4.50/share
GMDA prices offering. 13.33M shares at $4.50/share
MODERNA IS SAID TO OFFER SHARES AT $75.00 TO $77.50 EACH
MRNA $1.25b S-3ASR just filed
Moderna reported that its potential vaccine boosted the immune system of participants to the same or higher levels of protection as patients who had recovered from the disease
http://www.ft.com/cms/s/63ba718d-98e5-4873-aa1d-9f6fd912d8df,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo
BPMC Receives CRL For Avapritinib NDA
$SAVA halted... and #fails
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
BLUE $BMY FDA Determines CMC Module of BLA Requires Further Detail
What did you think of the data?
$MYOK prices 5.25m shares at $105/share
MYLAN AND GILEAD SCIENCES SIGN GLOBAL PACT FOR REMDESIVIR